Intelligent Surgical staff named in suit:
This article was originally published in Clinica
Officers and directors from Intelligent Surgical Lasers have been named as defendants in a class action suit related to the Blech securities litigation. Intelligent Surgical says it will vigorously contest the claims made against it.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.